[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350894-105":59,"doc-detail-350894-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","increased-sensitivity-of-etoposide-treated-breast-cancer-cells-with-an-atm-inhibitor","Increased sensitivity of etoposide-treated breast cancer cells with an ATM inhibitor","","Breast cancer remains a leading cause of cancer-related death in women, driving the need for targeted combination therapies that improve survival. Etoposide induces transient DNA double-strand breaks, and its action is strongest during S/G2 phases. The study tests whether inhibiting ATM, a DNA repair kinase active in homologous recombination, can enhance etoposide-mediated tumor cell death via synthetic lethal interactions. In vitro combination treatment increases apoptosis, DNA damage, chromosomal aberrations, and reduces cell viability using cytokinesis-block micronucleus, viability, and fluorescent staining assays.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/increased-sensitivity-of-etoposide-treated-breast-cancer-cells-with-an-atm-inhibitor/350894/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/increased-sensitivity-of-etoposide-treated-breast-cancer-cells-with-an-atm-inhibitor/350894.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is ATM inhibition considered alongside etoposide treatment in breast cancer cells?","Question",{"text":113,"@type":114},"ATM detects DNA double-strand breaks and activates homologous recombination repair and related checkpoint control. Inhibiting ATM can worsen DNA lesions produced by etoposide, increasing cell death.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What does “synthetic lethality” mean in this study’s context?",{"text":118,"@type":114},"It describes a situation where inhibiting or mutating two or more genes together produces greater cancer cell death than altering either gene alone.",{"name":120,"@type":111,"acceptedAnswer":121},"How did the researchers evaluate whether combination treatment increased DNA damage and cell death?",{"text":122,"@type":114},"They used a cytokinesis-block micronucleus assay to assess DNA damage and chromosomal aberrations, along with cell viability tests and fluorescent staining to measure the extent of cell death.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},350894,1790146146,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","OPEN ACCESS  \nCitation: Kumar ARK, Shaji CS, Rajagopalan A, Bhattacharya S, Martínez-López W, Saraswathy R (2026) Increased sensitivity of etoposidetreated breast cancer cells with an ATM inhibitor. PLoS One 21(1): e0340472. [https://](https://)[ ](https://)[doi.org/10.1371/journal.pone.0340472](doi.org/10.1371/journal.pone.0340472)  \n[Editor:](Editor: Vino Cheriyan)[ Vino Cheriyan](Editor: Vino Cheriyan), IHRC, Inc. (Human Resource Service Administration), UNITED STATES OF AMERICA  \nReceived: August 14, 2025  \nAccepted: December 22, 2025  \nPublished: January 20, 2026  \nCopyright: © 2026 Kumar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData availability statement: All relevant data are within the manuscript and its Supporting  Information files.  \nFunding: We acknowledge that the research was supported by Vellore Institute of Technology (VIT) Seed Grant Year 2020/2021 .  \nRESEARCH ARTICLE  \nIncreased sensitivity of etoposide-treated breast cancer cells with an ATM inhibitor  \nArun R. K. Kumar1,2, Crystal Sara Shaji1, Aswathi Rajagopalan1,  \nSombodhi Bhattacharya1, Wilner Martínez-López1,3, Radha Saraswathy1*  \n1 Biomedical Genetics Research Laboratory, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, India, 2 Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 3 Genetics Department and Biodosimetry Service, Instituto de Investigaciones Biologicas Clemente Estable, Montevideo, Uruguay  \n* [radhasaraswathy@vit.ac.in](radhasaraswathy@vit.ac.in)  \nAbstract  \nBreast cancer remains the leading cause of cancer-related deaths in women. Therefore, developing targeted combination therapies that improve overall survival in breast cancer patients continues to pose a major clinical challenge. Etoposide (ETO), a topoisomerase II inhibitor that induces transient double-strand breaks by blocking the cleavable complex, is currently used in high doses to treat radioresistant or metastatic breast cancers. To enhance the effectiveness of radiation and chemotherapy, targeting molecular mechanisms involved in DNA repair of induced DNA lesions could selectively increase tumor cell death. Since the effects of ETO are primarily seen during the S/G2 phases of the cell cycle, its efficacy could potentially be enhanced by using an inhibitor of a DNA repair gene involved in homologous recombination, which is mainly active during these phases. In this context, synthetic lethality refers to the concept that inhibiting or mutating two or more genes simultaneously leads to greater cell death than altering them individually. The FDA approval of Olaparib, a specific PARP inhibitor for BRCA-mutated breast cancer patients, has motivated researchers to explore other synthetic lethal interactions that could increase DNA damage accumulation, leading to cancer cell death. We demonstrate that successive treatment of breast cancer cells with specific inhibitors of ATM kinase and topoisomerase II in vitro can induce increased apoptosis. ATM is an apical kinase that recognizes DNA double-strand breaks and activates the homologous recombination repair pathway, either directly or through cell cycle checkpoint control. Topoisomerase II poisons generate enzyme-mediated DNA damage, leading to permanent double-strand breaks. Cytokinesis-block micronucleus assay was performed to assess the increase in DNA damage during combination treatment with inhibitors. Additionally, cell viability tests and fluorescent staining assay were conducted to evaluate the extent of cell death. We found that targeting ETO-treated breast cancer cells with an ATM kinase inhibitor, KU-55933 (KU) induced higher chromosomal damage/aberrations, as evaluated by  \nPLOS One | [https://doi.org/10.1371/journal.pone.0340472](https://doi.org/10.1371/journa","cbCaiiY9gOt5EnAP","https://ap.wps.com/l/cbCaiiY9gOt5EnAP","pdf",2613012,16,"English","# Abstract\n## Background and rationale\n## Synthetic lethality and target pathways\n## In vitro combination approach\n## Assays and key findings","[{\"question\":\"Why is ATM inhibition considered alongside etoposide treatment in breast cancer cells?\",\"answer\":\"ATM detects DNA double-strand breaks and activates homologous recombination repair and related checkpoint control. Inhibiting ATM can worsen DNA lesions produced by etoposide, increasing cell death.\"},{\"question\":\"What does “synthetic lethality” mean in this study’s context?\",\"answer\":\"It describes a situation where inhibiting or mutating two or more genes together produces greater cancer cell death than altering either gene alone.\"},{\"question\":\"How did the researchers evaluate whether combination treatment increased DNA damage and cell death?\",\"answer\":\"They used a cytokinesis-block micronucleus assay to assess DNA damage and chromosomal aberrations, along with cell viability tests and fluorescent staining to measure the extent of cell death.\"}]","Increased sensitivity of etoposide-treated breast cancer cells with an ATM inhibitor | PDF",1790091691,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75a5aebb3e0efe2e582aa1dd00968476.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c35f953b12d773bd497eeaa58153e509.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/15ec41fa00d05a36cdd3234807065aad.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25bbf1b57b52db09041094c17b85a934.webp",980,1268]